Cognition and Imaging With Tigertriever

Description

The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.

Conditions

Stroke

Talk to us

Study Overview

On this page

Study Details

Study overview

The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.

COGNITIVE Study- Cognition and Imaging With Tigertriever

Cognition and Imaging With Tigertriever

Condition
Stroke
Intervention / Treatment

-

Contacts and Locations

Los Angeles

University of California, Los Angeles, California, United States, 90095

New York

Westchester Medical Center, New York, New York, United States, 10595

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as indicated per the approved IFU.
  • 2. Tigertriever was used as the first line treatment in the target vessel.
  • 3. A signed informed consent.
  • 4. Age 18-75 years (inclusive).
  • 5. No known significant pre-stroke disability (pre-stroke mRS 0 or 1).
  • 1. Use of any other IA recanalization device prior to the Tigertriever in the target vessel, including aspiration catheter.
  • 2. Evidence of acute brain hemorrhage on CT and/or MRI at admission.
  • 3. Prior hemorrhage, stroke, thrombolysis, and/or endovascular therapy in the last 3 months.
  • 4. Probable cerebral amyloid angiopathy.
  • 5. Pre-stroke diagnosed dementia and/or prescribed cholinesterase inhibitors.
  • 6. Pre-stroke diagnosed and/or currently treated major depression.
  • 7. Pre-stroke learning or intellectual disability.
  • 8. Anticipated inability to obtain 6-month follow-up assessments.

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Rapid Medical,

Study Record Dates

2026-11